(Q41266366)

28 September 2017

title

Infliximab Does Not Worsen Outcomes During Flare-ups Associated with Cytomegalovirus Infection in Patients with Ulcerative Colitis (English)

1 reference

28 September 2017

0 references

cytomegaloviral disease

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25933392%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Philippe Berthelot

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25933392%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Bruno Pozzetto

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25933392%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Xavier Roblin

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25933392%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

8

Jean-Marc Phelip

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25933392%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Camille Jarlot

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25933392%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Mathilde Courault

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25933392%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Emilie Del Tedesco

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25933392%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Renaud Chardon

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25933392%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Pierre Saint-Sardos

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25933392%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Emilie Presles

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25933392%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

1 July 2015

1 reference

Inflammatory Bowel Diseases

28 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25933392%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25933392%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25933392%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

1580-1586

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25933392%20AND%20SRC:MED&resulttype=core&format=json

Cytomegalovirus colitis complicating inflammatory bowel disease

10 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

Management of cytomegalovirus infection in inflammatory bowel diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

Cytomegalovirus infection in patients with active inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

A multicenter experience with infliximab for ulcerative colitis: outcomes and predictors of response, optimization, colectomy, and hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

Developments in the treatment of moderate to severe ulcerative colitis: focus on adalimumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

Extracorporeal photopheresis (ECP) in patients with steroid-dependent Crohn's disease: an open-label, multicenter, prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

One-year maintenance outcomes among patients with moderately-to-severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

Review article: chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

Disseminated cytomegalovirus infection in Crohn's disease following anti-tumour necrosis factor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

Cytomegalovirus retinitis in a patient treated with anti-tumor necrosis factor alpha antibody therapy for rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

Cytomegalovirus hepatitis associated with use of anti-tumor necrosis factor-alpha antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

A model for identifying cytomegalovirus in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

Clinical use of anti-TNF therapy and increased risk of infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

Cytomegalovirus affects clinical outcome of infliximab in ulcerative colitis refractory to tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

Severe disease activity and cytomegalovirus colitis are predictive of a nonresponse to infliximab in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

Long-term efficacy of infliximab for refractory ulcerative colitis: results from a single center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

Cytomegalovirus infection and the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

Clinical utility of cytomegalovirus antigenemia assay and blood cytomegalovirus DNA PCR for cytomegaloviral colitis patients with moderate to severe ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

Cytomegalovirus infection in severe ulcerative colitis patients undergoing continuous intravenous cyclosporine treatment in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

Infliximab does not activate replication of lymphotropic herpesviruses in patients with refractory rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD-subgroup analyses across four randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

Role for tumor necrosis factor alpha in murine cytomegalovirus transcriptional reactivation in latently infected lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

Cytomegalovirus reactivation and tumour necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

A high prevalence of cytomegalovirus antigenaemia in patients with moderate to severe chronic plaque psoriasis: an association with systemic tumour necrosis factor alpha overexpression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

Diagnosis and treatment of ulcerative colitis with cytomegalovirus infection: importance of controlling mucosal inflammation to prevent cytomegalovirus reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

TNF-alpha is an important pathogenic factor contributing to reactivation of cytomegalovirus in inflamed mucosa of colon in patients with ulcerative colitis: lesson from clinical experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

Cytomegalovirus Infection in Patients Who Required Colectomy for Toxic Megacolon or Severe Steroid-Refractory Ulcerative Colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000412

10.1097/MIB.0000000000000412

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25933392%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1 reference